K193313

Substantially Equivalent

Elecsys Anti-TSHR

Applicant: Roche Diagnostics
Product code: JZO
Advisory panel: Immunology
Date received: 2019-11-29
Decision date: 2020-02-27
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Indianapolis, IN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.